Anticancer and Cytotoxicity Activity of Native and Modified Black Rice Flour on Colon Cancer Cell Lines

B Thanuja1, R Parimalavalli1, S Vijayanand2

  • 1Department of Food Science and Nutrition, Periyar University, Salem 636 011, Tamil Nadu, India.

Insights

Native black rice flour exhibits significant anticancer properties against colon cancer cells. Modified black rice flour showed weak cytotoxicity and was non-toxic to mouse embryo cells, indicating potential cancer-preventive phytochemicals.

Area of Science:

  • Food Science
  • Biotechnology
  • Cancer Research

Background:

  • Black rice flour contains phytochemicals with potential health benefits.
  • Understanding the cytotoxic effects of modified rice flour is crucial for food applications.

Purpose of the Study:

  • To evaluate the cytotoxicity of native and modified black rice flour.
  • To assess the anticancer potential against colon cancer (HCT116) and mouse embryo (3T3-L1) cell lines.

Main Methods:

  • Cytotoxicity was assessed using the MTT assay.
  • Rice flour samples underwent enzymatic modification and heat moisture treatment.
  • Half-maximal inhibitory concentration (IC50) values were determined for both cell lines.

Main Results:

  • Native black rice flour demonstrated significant cytotoxic and anticancer potential against HCT116 cells (IC50: 255.78 µg/mL).
  • Modified black rice flour showed weak cytotoxicity against HCT116 cells (IC50: 340.85 µg/mL).
  • Native and modified black rice flour exhibited weak to non-toxic effects on 3T3-L1 cells (IC50: 345.96 µg/mL and 1106.94 µg/mL, respectively).

Conclusions:

  • Native black rice flour possesses significant anticancer potential against colon cancer.
  • Modified black rice flour is non-toxic and may be suitable for food applications.
  • Phytochemicals in black rice flour may play a role in colon cancer prevention.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.3K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.0K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K